Study of TRC105 and Bevacizumab in Patients With Refractory Gestational Trophoblastic Neoplasia (GTN)
Conditions: Gestational Trophoblastic Neoplasia; Choriocarcinoma; Placental Site Trophoblastic Tumor; Epithelioid Trophoblastic TumorInterventions: Drug: TRC105; Drug: BevacizumabSponsor: Tracon Pharmaceuticals Inc.Not yet recruiting - verified January 2016 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 20, 2016 Category: Research Source Type: clinical trials
Single Patient Treatment Protocol of TRC105 Combined With Standard-dose Bevacizumab for a Single Patient With Metastatic And Refractory Choriocarcinoma
Condition: ChoriocarcinomaInterventions: Biological: TRC105; Biological: BevacizumabSponsor: Tracon Pharmaceuticals Inc.Enrolling by invitation - verified March 2015 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 5, 2015 Category: Research Source Type: clinical trials
DNA Analysis in Samples From Younger Patients With Germ Cell Tumors and Their Parents or Siblings
Conditions: Childhood Malignant Ovarian Germ Cell Tumor; Childhood Malignant Testicular Germ Cell Tumor; Ovarian Choriocarcinoma; Ovarian Embryonal Carcinoma; Ovarian Mixed Germ Cell Tumor; Ovarian Teratoma; Ovarian Yolk Sac Tumor; Testicular Choriocarcinoma; Testicular Embryonal Carcinoma; Testicular Seminoma; Testicular Teratoma; Testicular Yolk Sac TumorInterventions: Other: laboratory biomarker analysis; Other: questionnaire administrationSponsors: Children's Oncology Group; National Cancer Institute (NCI)Recruiting - verified May...
Source: ClinicalTrials.gov - September 13, 2011 Category: Research Source Type: clinical trials
